Under these conditions, the Candesartan-treated WT-mice developed bladder-tumors similar to those of untreated controls (Figure 2D), whereas Candesartan-treated Cx40−/− mice developed fewer and smaller tumors, similar to those of the untreated hypertensive companions (Figure 2D). This evidence concerns the gene GJA5 and urinary bladder neoplasm.